Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Piqray 150mg°


Contraindicated
Foetotoxicity

Contraindicated
Piqray 150mg° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharmaceuticals Corporation
Origin U.S.A.
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01XX65

Your comment will appear shortly after approval

Piqray 150mg° :

Revision Date : 01/05/2019


Effect Frequency
Abdominal pain Very Common
Activated partial thromboplastin time prolonged Very Common
Albumin low Very Common
Alopecia Very Common
ALT increased Very Common
Creatinine increased Very Common
Decreased appetite Very Common
Diarrhoea (Diarrhea) Very Common
Dry skin Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Fatigue Very Common
Gamma-GT increased Very Common
Glucose decreased Very Common
Glucose increased Very Common
Haemoglobin decreased Very Common
Headache Very Common
Hypercalcaemia Very Common
Hypokalaemia Very Common
Hypomagnesaemia Very Common
Lipase increased Very Common
Lymphocyte count decreased Very Common
Mucosal dryness Very Common
Mucosal inflammation Very Common
Nausea Very Common
Oedema peripheral Very Common
Platelet count decreased (Thrombocyte count decreased) Very Common
Pruritus Very Common
Pyrexia Very Common
Skin rash Very Common
Stomatitis Very Common
Urinary tract infection Very Common
Vomiting Very Common
Weight decreased (Weight loss) Very Common

Different Units By MoH Code

Revision Date : 01/05/2019

Revision Date : 01/05/2019

Piqray 150mg°  MoH 10345 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 56
Strength 150mg
Storage Condition <30°C protect from humidity & light
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 166219/1
Submission date 07/11/2019
Registration Year 16/07/2020
Withdrawn Date 01/02/2023


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info